Alzheon is a series c plus startup based in United States. 2 investors tracked.
Based in the United States, Alzheon is a startup founded in 2013. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Alzheon, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drugs for patients suffering from Alzheimer's disease and other neurodegenerative disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.